Drug InfoNet.com
Ask the Expert
Drug Information
Disease Information
Health News
Health Info
Panel Registration
Healthcare Orgs
Medical Refs
Gov't Sites
Med Schools
Special Offers

Drug Infonet provides drug and disease information for your healthcare needs. Visit our FAQ page to find answers to common health questions. Look on the Manufacturer Info page to link to pharmaceutical company pages. Click to Health Info and Health News for the latest in healthcare developments.

Drug Infonet brings this free resource to you so that you become a more informed consumer of healthcare.

Doctors' Answers to "Frequently Asked Questions" - Naproxen Sodium

These comments are made for the purpose of discussion and should NOT be used as recommendations for or against therapies or other treatments. An individual patient is always advised to consult their own physician.

Warts & Grapefruit
Question:Can taking 880mg of NAPROXEN SODIUM (Aleve) per day result in a person: 1. losing their ability to maintain attention. 2. mask symptoms of pain excessively. 3. reduce the persons ability to understand what they have read. All of these symptoms were experienced by a patient who was taking 880mg of NAPROXEN SODIUM (Aleve) a day for about a year straight.

Answer: Naproxen sodium has been around a long time and used for treatment of several conditions requiring a non-steroidal anti-inflammatory. The prescription dosage ranges from 700 mg a day to 1000 mg a day. At this dosage, most patients will not experience the problems you are describing. However, if the attention deficit goes away with stoppage I guess it is a possibility. I wouldn't suspect this as the cause unless it started with the initial dosage.

Back to Drug InfoNet Home Page.

Back to Medication/Pharmaceutical main page.

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2005 DRUG INFONET, Inc. All rights reserved.